CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service · Privacy FAQ

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Certara›
Products & Services›
CoAuthor
CoAuthor

Certara› offers CoAuthor

ProductOperating Status: Currently Offered

CoAuthor is Certara's generative AI assistant for regulatory and medical writing inside Microsoft Word.

Loading
Overview

CoAuthor, from Certara, applies generative AI to regulatory writing workflows, drafting clinical and regulatory documents directly inside Microsoft Word on a biomedical-tuned language model.

The product serves medical writers preparing regulatory submissions, reducing drafting timelines from days or weeks to minutes for documents such as clinical study reports and other submission content.

CoAuthor - Classification

Tags
  • AI

More from Certara

  • D360 logo

    D360

CoAuthor - Direct Competitors

  • Biolevate

    Biolevate logo

    Biolevate AI-native Knowledge Platform

    biolevate.com

  • Bluenote

    Bluenote logo

    Bluenote Regulatory AI Platform

    bluenote.ai

  • Amia.ai

    Amia.ai logo

    Compliant Document Generator

    amia.ai

  • Veeva Systems

    Veeva Systems logo

    Veeva Submissions

    veeva.com

  • Weave

    Weave logo

    Weave Regulatory Platform

    weave.bio

  • Yseop

    Yseop logo

    Yseop Copilot

    yseop.com

AttributeCoAuthorBiolevate AI-native Knowledge PlatformBluenote Regulatory AI PlatformCompliant Document GeneratorVeeva SubmissionsWeave Regulatory PlatformYseop Copilot
ProviderCertaracertara.comBiolevatebiolevate.com36M raised · Series ABluenotebluenote.ai10M raised · Series AAmia.aiamia.aiVeeva Systemsveeva.comPublicWeaveweave.bio13M raised · Series AYseopyseop.com
Founded20082024202220232007—2008
Sells ToPharmaceutical Manufacturers—PharmaceuticalEnterpriseEnterpriseEnterprise—
Pricing Model——B2B SubscriptionSubscriptionRecurringRecurring, Software—
Ownership———PrivatePublicVenture Capital—
CoAuthor

Provider Certaracertara.com

Founded 2008

Sells To Pharmaceutical Manufacturers

Pricing Model —

Ownership —

Biolevate AI-native Knowledge Platform

Provider Biolevatebiolevate.com36M raised · Series A

Founded 2024

Sells To —

Pricing Model —

Ownership —

Bluenote Regulatory AI Platform

Provider Bluenotebluenote.ai10M raised · Series A

Founded 2022

Sells To Pharmaceutical

Pricing Model B2B Subscription

Ownership —

Compliant Document Generator

Provider Amia.aiamia.ai

Founded 2023

Sells To Enterprise

Pricing Model Subscription

Ownership Private

Veeva Submissions

Provider Veeva Systemsveeva.comPublic

Founded 2007

Sells To Enterprise

Pricing Model Recurring

Ownership Public

CoAuthor - Similar Products & Services

  • Writer Enterprise AI logo

    Writer Enterprise AI

  • AI Content Writing Platform logo

    AI Content Writing Platform

  • Claude Cowork logo

    Claude Cowork

    anthropic.com

  • Regulatory Intelligence Copilot logo

    Regulatory Intelligence Copilot

  • AI Pathology Scribe logo

    AI Pathology Scribe

  • Creative AI Suite logo

    Creative AI Suite

    treasure.ai

  • Canva AI logo

    Canva AI

    canva.com

  • Carson — AI Workspace logo

    Carson — AI Workspace

  • Patent Drafting logo

    Patent Drafting

    ipauthor.com